Pharmaceutical

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.

Oct 22, 2024 - 04:00
ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.
Read the original article

Tags:

Previous Article

Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs

Next Article

FibroBiologics and Charles River link for chronic disease therapies manufacture

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software

STAT+: Microsoft to embed AI tool for clinical document...

Jan 18, 2024

Innate Pharma plans IND of ADC candidate after positive preclinical data

Innate Pharma plans IND of ADC candidate after positive...

Apr 11, 2024

STAT+: FDA approves AstraZeneca, Ionis treatment for rare nerve disease

STAT+: FDA approves AstraZeneca, Ionis treatment for ra...

Dec 23, 2023